Adaptation of Clinical Laboratories to COVID 19 Pandemic: Changes in Test Panels, Overcoming Problems and Preparation Suggestions for Future Pandemics Adaptation of Clinical Laboratories to COVID 19 Pandemic

Basit Öğe Kaydı
dc.authoridKaradeniz, Aslı/0000-0003-3799-1090en_US
dc.authoridAtmaca, Onat/0000-0001-9632-8905en_US
dc.authoridSitar, Mustafa Erinc/0000-0001-5114-8660en_US
dc.contributor.authorÖngen İpek, Belkız
dc.contributor.authorSitar, Mustafa E.
dc.contributor.authorKaradeniz, Asli
dc.date.accessioned2024-07-12T21:37:36Z
dc.date.available2024-07-12T21:37:36Z
dc.date.issued2020en_US
dc.department[Belirlenecek]en_US
dc.description.abstractBackground: For Coronavirus Disease 2019 (Covid-19) infection, clinical laboratories provide essential contributions in the diagnosis of infection, stage prognostication, and evaluation of disease severity. We aimed to show laboratory problems including changes of test numbers, changes of test panels, and differences of preanalytical errors during Covid-19 pandemic and, in the current study, we also intended to give solutions for the obstacles to guide other possible pandemics. Methods: Our study was based on data between January 10, 2020, and May 10, 2020. The first Covid-19 case of the Republic of Turkey was seen March 10, 2020, which was determined as the threshold date for comparisons. This was a single center, data mining, retrospective study. Results: The number of patients admitted to hospital were 34,260 and 15,573, the number of total tests were 66,263 and 42,066 before and after pandemic, respectively, for the two-month interval. Test percentage changes were increased for D-dimer 136%, fibrinogen 3,113%, troponin 6%, and LDH 17%. Test percentage changes were decreased for CBC 37%, sedimentation 45%, aPTT 30%, PT 37%, CRP 28%, ProCT 10%, ferritin 29%, CK-MB 27%, blood gases 47%, ALT 43%, AST 42%, urea 42%, creatinine 42%, triglycerides 45%, sodium 42%, potassium 41%, chloride 21%, urine culture 58%, and blood culture 44%. When preanalytical sources of errors were investigated no differences were found. Conclusions: Laboratories must take quick action and be prepared for changes in patient services during pandemics. The most reliable ways for this are past experiences, statistical analysis, co-operation with administrations, high quality communication skills, and a risk-based management system.en_US
dc.identifier.doi10.7754/Clin.Lab.2020.200624
dc.identifier.endpage2340en_US
dc.identifier.issn1433-6510
dc.identifier.issue11en_US
dc.identifier.pmid33180431en_US
dc.identifier.scopus2-s2.0-85096082571en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage2335en_US
dc.identifier.urihttps://doi.org/10.7754/Clin.Lab.2020.200624
dc.identifier.urihttps://hdl.handle.net/20.500.12415/6863
dc.identifier.volume66en_US
dc.identifier.wosWOS:000590420300023en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherClin Lab Publen_US
dc.relation.ispartofClinical Laboratoryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY04205
dc.subjectCovid 19en_US
dc.subjectClinical Laboratory Problemsen_US
dc.subjectPandemicen_US
dc.subjectPre-Analytical Errorsen_US
dc.titleAdaptation of Clinical Laboratories to COVID 19 Pandemic: Changes in Test Panels, Overcoming Problems and Preparation Suggestions for Future Pandemics Adaptation of Clinical Laboratories to COVID 19 Pandemicen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu